# Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer

> **NCT00134355** · PHASE2 · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 5 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** PTK787

## Key facts

- **NCT ID:** NCT00134355
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2006-11
- **Final completion:** 2007-03
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2015-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00134355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00134355, "Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00134355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*